Inhibition of TPT1 by binding an anti-malaria drug, Dihydroartemisinin (DHA), to its phosphorylated form in breast cancer cell lines reduced cell growth and induced apoptosis (Lucibello et al., 2015). This evidence concerns the gene TPT1 and breast carcinoma.